Personalized medicine is becoming increasingly significant in neonatal care. By leveraging genetic information, healthcare providers can tailor treatments to the specific needs of each neonate. This approach minimizes the risks associated with generalized treatments and enhances the efficacy of interventions. For example, specific genetic markers can guide the use of targeted therapies in treating metabolic disorders.